RxDoctor Payments Data

Adrian Wiestner

Hematology · Bethesda, MDNPI 1942075114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Genmab U.S., Inc.. That places this record below the midpoint for hematology clinicians in MD, where the typical reported total is $129.

$55in general payments, 2019–2025

Across 2 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genmab U.S., Inc.$55
$7,416,425in research payments, 2019–2025

Across 9 payments — averaging $824,047 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$4.7M
  • AbbVie$2.2M
  • Genmab A/s$530K
  • Merck$70K

What the payments were for

  • Food & beverage$55100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genmab U.S., Inc.2$55

How this compares

$55 in reported general payments places this provider in the 30th percentile of 28 hematology providers in Maryland.

See all hematology providers in Maryland →

Other hematology in Bethesda

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →